These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 16718634)

  • 1. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
    Ferrante E; Giavoli C; Porretti S; Vassallo E; Ronchi CL; Lania AG; Beck-Peccoz P; Spada A
    Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
    Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
    Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the IGF system in 15 patients with Alström syndrome.
    Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
    Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects.
    Kanaley JA; Frystyk J; Møller N; Dall R; Chen JW; Nielsen SC; Christiansen JS; Jørgensen JO; Flyvbjerg A
    Growth Horm IGF Res; 2005 Aug; 15(4):283-90. PubMed ID: 16027018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
    Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
    Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of the measurement of insulin-like growth factor (IGF-I) and IGF-1 binding protein-3 (IGFBP-3) for the diagnosis of growth hormone (GH) deficiency in children].
    Codner E; Méricq V; Ugarte F; Iñíguez G; Espinoza M; Avila A; Salazar T; Cassorla F; García H
    Rev Med Chil; 1999 Jul; 127(7):807-13. PubMed ID: 10668288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience in identical twins discordant for adult-onset growth hormone deficiency.
    Simpson H; Camcho-Hübner C; Sönksen P; Russell-Jones D
    J Endocrinol Invest; 1999; 22(5 Suppl):61-3. PubMed ID: 10442573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment.
    Zimmermann-Belsing T; Juul A; Juul Holst J; Feldt-Rasmussen U
    Growth Horm IGF Res; 2004 Jun; 14(3):235-44. PubMed ID: 15125885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
    Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease.
    Fischer F; Schulte H; Mohan S; Tataru MC; Köhler E; Assmann G; von Eckardstein A
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):595-602. PubMed ID: 15521962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-I, IGF-II, IGFBP2, IGFBP3 and acid-labile subunit (ALS) in colorectal cancer patients before surgery and during one year follow up in relation to age.
    Sztefko K; Hodorowicz-Zaniewska D; Popiela T; Richter P
    Adv Med Sci; 2009; 54(1):51-8. PubMed ID: 19482725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.